Standard

Expansion

Investor Relations
Investor Relations

Investor Relations >

Message from the President IR News Financial/Capital Strategy

Management Policy
and Plan

Business/
Financial Information

IR Library

Sustainability Management

Stock and
Shareholder Information

To Our Individual Investors

> IR Calendar

> Stock Quotes

> Analyst Coverage

> Electronic Announcements

> Information Disclosure Policy

> IR e-mail

> IR Information Site Map
Sustainability
Sustainability

Sustainability >

Message from the Chairman

How We View Sustainability

Nippon Shinyaku Group’s
Issues of Materiality

> ESG Data

> GRI Standards Content Index

> Recognition by external parties

> The United Nations
Global Compact

> Annual Report

Human Capital

> Labor Practices

> DE&I

> Safety and Health

> Health and Productivity Management

> Well-being Management

> Human Resources

The Environment

> Environmental Management

> Disclosure Based on the TCFD Recommendations

> Response to Climate Change

> Promoting the Recycling of Resources

> Conservation of Biodiversity

> Responses to Other Environmental Issues

Society

> Human Rights

> Supply Chain Management

> Contribution to children and local communities

> Improving medical access

> Customer Responsibility

Governance

> Corporate Governance

> Compliance/
Risk Management

> Transparency Guidelines

> Dialogue with Outside Directors

> ESG Data

> GRI Standards Content Index

> Recognition by external parties

> The United Nations
Global Compact

> Annual Report
R&D
R&D

R&D TOP >

Basic Policy for R&D / Intellectual Property

R&D Organization

Drug Discovery Research

Clinical Development

Partnering

Ethical Consideration in R&D

> Glossary of Terms
Who we are
Who we are

Who we are TOP >

> Message from the Chairman Shigenobu Maekawa

> Message from the President Toru Nakai

Company Information

Corporate Philosophy

Nippon Shinyaku’s DNA

Company History

Videos and Advertisements

Digital transformation (DX)

Pharmaceuticals Division

> Research & Development

> Medical Affairs

> Sales

> Production

> Global Expansion

> Reliability Assurance

> Main Products

Functional Food Division

> Research & Development

> Quality Assurance

> Product Information

> Functional Food Division Website
JAPANESE CONTACT
CLOSE

Top
To Our Shareholders and Investors
Stock Quotes

Stock Quotes

Related Link

Nippon Shinyaku’s DNA

Research & Development

Top
To Our Shareholders and Investors
Stock Quotes

Investor Relations
Sustainability
R&D
Who we are
News

About the use of this website
Accessibility
Privacy Policy
Social Media Policy
Contact
Site Map

Official YouTube Channel

©2025 NIPPON SHINYAKU CO., LTD.